N2-Boc-N6-(2,2,2-trifluoroacetyl)-L-lysine

Catalog No. :
ACQAIP618
CAS No. :
16965-06-3
Molecular Formula :
C13H21F3N2O5
Molecular Weight :
342.31

IUPAC Name:N2-(tert-butoxycarbonyl)-N6-(2,2,2-trifluoroacetyl)-L-lysine

N2-Boc-N6-(2,2,2-trifluoroacetyl)-L-lysine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100g98%$169.00Login to see priceIn stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameN2-Boc-N6-(2,2,2-trifluoroacetyl)-L-lysine
IUPAC NameN2-(tert-butoxycarbonyl)-N6-(2,2,2-trifluoroacetyl)-L-lysine
MDL No.MFCD00037104
Molecular FormulaC13H21F3N2O5
Molecular Weight342.31
SMILESO=C(O)[C@@H](NC(OC(C)(C)C)=O)CCCCNC(C(F)(F)F)=O
InChI KeyDEIYNDIFGSDDCY-QMMMGPOBSA-N
SynonymBoc-Lys(Tfa)-OH | 16965-06-3 | (S)-2-((tert-Butoxycarbonyl)amino)-6-(2,2,2-trifluoroacetamido)hexanoic acid | N2-Boc-N6-(2,2,2-trifluoroacetyl)-L-lysine | C13H21F3N2O5 | MFCD00037104 | SCHEMBL1603617 | DTXSID00426564 | N2-BOC-N6-trifluoroacetyl-L-lysine | (2S)-2-{[(tert-bu
CAS No.16965-06-3
PubChem CID7009540

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P305+P351+P338

Synthetic Route by SureRoute

1. ACQAIP618 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACLRNE639 route compound structure diagram
    ACLRNE63934619-03-9 In Stock
  2. Plus
  3. ACMPQJ298 route compound structure diagram
    ACMPQJ29810009-20-8 In Stock
  4. Then
  5. ACQAIP618 route product structure diagram
    ACQAIP61816965-06-3 In Stock
Inquiry

2. ACQAIP618 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACMPQJ298 route compound structure diagram
    ACMPQJ29810009-20-8 In Stock
  4. Then
  5. ACQAIP618 route product structure diagram
    ACQAIP61816965-06-3 In Stock
Inquiry

Comments (0)